Examining Viral Infections in Immune Deficiencies

Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency

Recruiting Observational Study
Humoral Primary Immunodeficiencies (PIDs) Secondary Form of Humoral Immunodeficiencies Combined Immunodeficiency (CID) Severe Combined Immunodeficiency (SCID)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
120 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Who this trial is looking for

This trial is looking for patients with specific immune deficiencies to study how chronic viral infections may affect their liver health. Participants will have their blood, stool, and urine samples collected for testing.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am a patient with no age limit
  • I have humoral primary immunodeficiencies
  • I have secondary humoral immunodeficiencies after certain therapies
  • I have combined immunodeficiency
  • I have severe combined immunodeficiency beyond 2 years post cell therapy

You may not be able to join if

  • I do not belong to one of the target populations
  • I or my legal representative oppose my participation

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Dysimmune and specially hepatic immuno-pathological processes are frequent in patients with PIDs (primary immune deficiencies), particularly but not exclusively in patients with humoral defects. In the latter, nodular regenerative hyperplasia is a frequent complication. It is often associated with mislabeled chronic enteropathy. The investigators hypothesized that chronic viral infection with an e…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: \- Information and non-opposition from the legal representatives of minor patients, the patients themselves and adult patients of the population of interest. Population of interest: Patients with no age limit followed in one of the skills centers of the Reference Center for He…
Contacts

Victor Michel, MD

1 42 75 44 35

victor.michel@institutimagine.org

CONTACT

Hélène Morel

1 71 19 63 46

helene.morel@aphp.fr

CONTACT